/LXXGF
LXXGF Stock - LexaGene Holdings Inc.
Healthcare|Medical - DevicesOTC
$0.08+0.00%
+$0.00 (+0.00%) • Feb 21
46
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.14
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.39
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.09
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for LXXGF
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.08 – $0.08
TARGET (TP)$0.09
STOP LOSS$0.07
RISK/REWARD1:0.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta2.04
52W High$0.22
52W Low$0.05
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|
| Revenue | $75,314 | $58,125 | N/A | N/A | N/A |
| Gross Profit | $-468,000 | $-101,000 | N/A | N/A | N/A |
| Gross Margin | -621.4% | -173.8% | N/A | N/A | N/A |
| Operating Income | $-10,638,000 | $-9,816,000 | $-7,400,000 | $-8,324,000 | $-3,950,000 |
| Net Income | $-10,620,000 | $-9,966,000 | $-7,601,000 | $-8,320,000 | $-4,033,000 |
| Net Margin | -14101.0% | -17145.8% | N/A | N/A | N/A |
| EPS | $-0.09 | $-0.10 | $-0.10 | $-0.13 | $-0.08 |
Company Overview
LexaGene Holdings Inc., a biotechnology company, engages in the research, development, and commercialization of pathogen detection systems. It offers MiQLab, an automated pathogen detection system that aims to transform pathogen detection in veterinary diagnostics, human clinical diagnostics, food and water safety testing, and other life sciences markets. Its automated pathogen detection platform is used at the site of sample collection, which offers unprecedented ease-of-use, sensitivity, and breadth of pathogen detection. The company was incorporated in 2007 and is headquartered in Beverly, Massachusetts.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
LXXGFBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$-0.01
Q1 2023
EPS Surprise History
Q1 21
No data
Q3 21
No data
Q4 21
No data
Q1 22
No data
Q1 22
No data
Q3 22
No data
Q4 22
No data
Q1 23
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q1 2023 | Jan 17, 2023 | — | $-0.01 | — | — |
Q4 2022 | Oct 18, 2022 | — | $-0.01 | — | — |
Q3 2022 | Jul 27, 2022 | — | $-0.02 | — | — |
Q1 2022 | Feb 28, 2022 | — | $-0.02 | — | — |
Q1 2022 | Jan 31, 2022 | — | $-0.02 | — | — |
Q4 2021 | Oct 26, 2021 | — | $-0.02 | — | — |
Q3 2021 | Jul 30, 2021 | — | $-0.02 | — | — |
Q1 2021 | Feb 28, 2021 | — | $-0.02 | — | — |
Q1 2021 | Jan 29, 2021 | — | $-0.03 | — | — |
Q4 2020 | Oct 29, 2020 | — | $-0.02 | — | — |
Q3 2020 | Jul 30, 2020 | — | $-0.03 | — | — |
Q1 2020 | Feb 29, 2020 | — | $-0.02 | — | — |
Q1 2020 | Jan 27, 2020 | — | $-0.04 | — | — |
Q4 2019 | Oct 30, 2019 | — | $-0.02 | — | — |
Q2 2019 | May 31, 2019 | — | $-0.03 | — | — |
Q1 2019 | Feb 28, 2019 | — | $-0.03 | — | — |
Q4 2018 | Nov 30, 2018 | — | $-0.03 | — | — |
Q3 2018 | Aug 31, 2018 | — | $-0.03 | — | — |
Q2 2018 | May 31, 2018 | — | $-0.03 | — | — |
Q1 2018 | Feb 28, 2018 | — | $-0.02 | — | — |
Latest News
Loading news...
Frequently Asked Questions about LXXGF
What is LXXGF's current stock price?
LexaGene Holdings Inc. (LXXGF) is currently trading at $0.08 per share. The stock has moved +0.00% today.
What is the analyst price target for LXXGF?
No analyst price targets are currently available for this stock.
What sector is LexaGene Holdings Inc. in?
LexaGene Holdings Inc. operates in the Healthcare sector, specifically within the Medical - Devices industry. The company is traded on the OTC exchange.
What is LXXGF's market cap?
LexaGene Holdings Inc. has a market capitalization of $0.01 billion, making it a small-cap company.
Does LXXGF pay dividends?
No, LexaGene Holdings Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorATBPF
Antibe Therapeutics Inc.
$0.22
Mkt Cap: $0.0B
AVEFF
Avecho Biotechnology Limited
$0.00
Mkt Cap: $0.0B
CDXFF
Cloud DX Inc.
$0.09
Mkt Cap: $0.0B
CNPOF
RIV Capital Inc.
$0.08
Mkt Cap: $0.0B
EIGRQ
Eiger BioPharmaceuticals, Inc.
$8.50
Mkt Cap: $0.0B
LVCLY
Living Cell Technologies Limited
$0.03
Mkt Cap: $0.0B
MGCLF
MGC Pharmaceuticals Limited
$0.27
Mkt Cap: $0.0B
RXMD
Progressive Care, Inc.
$2.11
Mkt Cap: $0.0B
TMDIF
Titan Medical Inc.
$0.82
Mkt Cap: $0.0B
VRCDF
Verici Dx plc
$0.00
Mkt Cap: $0.0B
Explore stocks similar to LXXGF for comparison